“…In this study, we used soluble proteins from twelve H. pylori strains (three clinical isolates from dyspeptic patients, two from chronic gastritis patients, three from patients with peptic ulcers, two from patients with gastric cancer and two reference strains [Hp 26695 (ATCC 700392) and Hp J99 (ATCC 700824)]) and 44 serum samples [from 12 patients with dyspepsia, five with peptic ulcer, 13 with bleeding peptic ulcers and 14 with gastric cancer (six with early and eight with advance gastric cancer)] that were obtained from two previous studies [14,15], in which patients with gastric or duodenal ulcers with ongoing or recent (<24 h) bleeding were recruited, as well two groups were included simultaneously in the study as controls: patients with non-bleeding peptic ulcers and those in whom an endoscopy was performed because of non-ulcer dyspepsia and ⁄ or gastro-oesophageal reflux. Patients were excluded if they were pregnant, were regular users of non-steroidal anti-inflammatory drugs (NSAIDs), were sporadic users of NSAIDs within the previous 2 weeks, were carriers of a chronic liver disease, had a history of bleeding portal hypertension or were unable to make their own decisions.…”